Arthrex Knee FiberTak® Button Suture Anchor

K232973 · Arthrex, Inc. · MBI · Nov 15, 2023 · Orthopedic

Device Facts

• Record ID: K232973
• Device Name: Arthrex Knee FiberTak® Button Suture Anchor
• Applicant: Arthrex, Inc.
• Product Code: MBI · Orthopedic
• Decision Date: Nov 15, 2023
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3040
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Arthrex Knee FiberTak® Button Suture Anchor is intended for fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, elbow, and hip in the following procedures: · Shoulder: Rotator cuff repair, Bankart repair, SLAP lesion repair, biceps tenodesis, acromio-clavicular separation repair, deltoid repair, capsular shift or capsulolabral reconstruction · Foot/Ankle: Lateral stabilization, medial stabilization, achilles tendon repair, mid-foot reconstruction, hallux valgus reconstruction, metatarsal ligament repair, and digital tendon transfers · Knee: Medial collateral ligament repair, lateral ligament repair, patellar tendon, posterior oblique ligament repair, iliotibial band tenodesis, joint capsule closure, medial patellofemoral ligament repair/reconstruction, and quadriceps tendon repair · Hand/Wrist: Scapholunate ligament reconstructions, repair/reconstructions, repair/reconstruction of collateral ligaments digital tendon transfers, and carpometacarpal joint arthroplasty (basal thumb joint arthroplasty) · Elbow: Biceps tendon reattachment, ulnarradial collateral ligament reconstruction, and lateral epicondylitis repar · Hip: Acetabular Labral Repair and gluteal tendon repair

Device Story

All-suture soft-tissue anchor; constructed from hollow polyester braid with UHMWPE or UHMWPE/polyester blend suture; pre-loaded on disposable inserter. Used by surgeons in orthopedic procedures to fixate soft tissue to bone. Device functions by anchoring suture into bone to facilitate tissue repair. Sold sterile for single use. Mechanical performance verified via ultimate load and cyclic displacement testing.

Clinical Evidence

Bench testing only. Ultimate load testing and cyclic displacement testing performed to demonstrate mechanical equivalence.

Technological Characteristics

All-suture anchor; hollow polyester braid; UHMWPE or UHMWPE/polyester blend suture; disposable inserter; sterile; single-use.

Indications for Use

Indicated for soft tissue-to-bone fixation in shoulder, foot/ankle, knee, hand/wrist, elbow, and hip procedures, including specific ligament, tendon, and joint repairs/reconstructions across these anatomical sites.

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• Arthrex FiberTak® Suture Anchor (K231330)
• Arthrex BioComposite SwiveLock® (K180768)

Submission Summary (Full Text)

{0}------------------------------------------------

November 15, 2023

Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Arthrex Inc Kristi Frisch Regulatory Affairs Specialist, Principal 1370 Creekside Boulevard Naples, Florida 34108-1945

Re: K232973

Trade/Device Name: Arthrex Knee FiberTak® Button Suture Anchor Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: MBI Dated: September 19, 2023 Received: September 21, 2023

Dear Kristi Frisch:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"

{1}------------------------------------------------

(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely.

# Sara S. Thompson -S

For

Jesse Muir, Ph.D. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices

{2}------------------------------------------------

Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

### Indications for Use

510(k) Number (if known) K232973

#### Device Name

Arthrex Knee FiberTak® Button Suture Anchor

The Arthrex Knee FiberTak® Button Suture Anchor is intended for fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, elbow, and hip in the following procedures:

· Shoulder: Rotator cuff repair, Bankart repair, SLAP lesion repair, biceps tenodesis, acromio-clavicular separation repair, deltoid repair, capsular shift or capsulolabral reconstruction

· Foot/Ankle: Lateral stabilization, medial stabilization, achilles tendon repair, mid-foot reconstruction, hallux valgus reconstruction, metatarsal ligament repair, and digital tendon transfers

• Knee: Medial collateral ligament repair, lateral ligament repair, patellar tendon, posterior oblique ligament repair, iliotibial band tenodesis, joint capsule closure, medial patellofemoral ligament repair/reconstruction, and quadriceps tendon repair

· Hand/Wrist: Scapholunate ligament reconstructions, repair/reconstructions, repair/reconstruction of collateral ligaments digital tendon transfers, and carpometacarpal joint arthroplasty (basal thumb joint arthroplasty)

· Elbow: Biceps tendon reattachment, ulnarradial collateral ligament reconstruction, and lateral epicondylitis repar

· Hip: Acetabular Labral Repair and gluteal tendon repair

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

## 510(k) Summary

| Date Prepared | November 14, 2023 |
|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter | Arthrex Inc.<br>1370 Creekside Boulevard<br>Naples, FL 34108-1945 |
| Contact Person | Kristi Frisch<br>Regulatory Affairs Specialist, Principal<br>Tel [phone] x73849<br>[e-mail] |
| Trade Name | Arthrex Knee FiberTak® Button Suture Anchor |
| Common Name | Suture Anchor |
| Product Code | MBI |
| Classification Name | 21 CFR 888.3040: Smooth or threaded metallic bone fastener |
| Regulatory Class | II |
| Primary Predicate Device | K231330: Arthrex FiberTak® Suture Anchor |
| Additional Predicate Device | K180768 Arthrex BioComposite SwiveLock® |
| Purpose of Submission | This Traditional 510(k) premarket notification is submitted to expand<br>indications of the Arthrex Knee FiberTak® Button Suture Anchor to<br>include quadriceps tendon repair. |
| Device Description | The Arthrex Knee FiberTak® Button Suture Anchor is an 'all-suture' soft-<br>tissue device intended to be used for fixation of suture (soft tissue) to<br>bone in the shoulder, foot/ankle, knee, hand/wrist, elbow, and hip.<br><br>The anchor is constructed from a hollow braid of polyester with a single<br>loaded suture component composed of UHWMPE or a polyblend of<br>UHMWPE and polyester.<br><br>The anchor is pre-loaded on a disposable inserter and will be sold sterile<br>for single use |
| Indications for Use | The Arthrex Knee FiberTak® Button Suture Anchor is intended for<br>fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee,<br>hand/wrist, elbow, and hip in the following procedures:<br>Shoulder: Rotator cuff repair, Bankart repair, SLAP lesion repair,<br>biceps tenodesis, acromio-clavicular separation repair, deltoid<br>repair, capsular shift or capsulolabral reconstruction Foot/Ankle: Lateral stabilization, medial stabilization, achilles<br>tendon repair, mid-foot reconstruction, hallux valgus<br>reconstruction, metatarsal ligament repair, and digital tendon<br>transfers Knee: Medial collateral ligament repair, lateral collateral ligament<br>repair, patellar tendon, posterior oblique ligament repair, iliotibial<br>band tenodesis, joint capsule closure, medial patellofemoral<br>ligament repair/reconstruction, and quadriceps tendon repair Hand/Wrist: Scapholunate ligament reconstruction, carpal ligament<br>reconstructions, repair/reconstruction of collateral ligaments digital<br>tendon transfers, and carpometacarpal joint arthroplasty<br>(basal thumb joint arthroplasty) Elbow: Biceps tendon reattachment, ulnar/radial collateral ligament<br>reconstruction, and lateral epicondylitis repair |

{5}------------------------------------------------

| Performance Data | Ultimate load testing and cyclic displacement was performed on the<br>subject device to demonstrate that the differences do not negatively<br>impact mechanical strength. |
|--------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technological Comparison | The proposed Arthrex Knee FiberTak® Button Suture Anchor device and<br>predicate device (K231330) have the same scientific technology,<br>packaging, sterility, shelf-life, and MRI safety labeling. The proposed<br>device modification consists of the addition of the quadriceps tendon<br>repair indication. The additional predicate device Arthrex BioComposite<br>SwiveLock® is comparable in design, intended use and inclusion of the<br>quadriceps tendon repair indication.<br>The Arthrex Knee FiberTak® Button Suture Anchor is substantially<br>equivalent to the predicate device in which the design features and<br>intended uses are identical.<br>Any differences between the proposed device and the predicate device<br>are considered minor and do not raise questions concerning safety or<br>effectiveness. |
| Conclusion | The Arthrex Knee FiberTak® Button Suture Anchor is substantially<br>equivalent to the predicate devices cleared under K231330 in which the<br>basic design features and intended use are identical. Any differences<br>between the Arthrex Knee FiberTak® Button Suture Anchor and the<br>predicate devices are considered minor and do not raise different<br>questions of safety or effectiveness.<br>The submitted mechanical testing data demonstrates that the Arthrex<br>Knee FiberTak® Button Suture Anchor is substantially equivalent to that<br>of the predicate devices for the desired indication.<br>Based on the indications for use, technological characteristics, and the<br>summary of data submitted, Arthrex Inc. has determined that the<br>proposed device is substantially equivalent to the currently marketed<br>predicate devices. |